OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sporozoite immunization: innovative translational science to support the fight against malaria
Thomas L. Richie, L. W. Preston Church, Tooba Murshedkar, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 964-1007
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Malaria vaccines: a new era of prevention and control
Patrick E. Duffy, J. Patrick Gorres, Sara A. Healy, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 756-772
Closed Access | Times Cited: 19

Vaccines and monoclonal antibodies: new tools for malaria control
Kazutoyo Miura, Yevel Flores-García, Carole A. Long, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 11

Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Halimatou Diawara, Sara A. Healy, Agnes Mwakingwe-Omari, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 12, pp. 1366-1382
Closed Access | Times Cited: 11

Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite
Olivia A.C. Lamers, Blandine Franke‐Fayard, Jan Pieter R. Koopman, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 20, pp. 1913-1923
Closed Access | Times Cited: 10

Whole-genome sieve analysis: Identification of protective malaria antigens by leveraging allele-specific vaccine efficacy
Ryan J. Scalsky, Ankit Dwivedi, Thomas C. Stabler, et al.
Vaccine (2025) Vol. 50, pp. 126783-126783
Closed Access | Times Cited: 1

Setting sights on a single-shot malaria vaccine
Debashree Goswami, Stefan H. I. Kappe
Nature Medicine (2025)
Closed Access

Liver stage P. falciparum antigens highly targeted by CD4+ T cells in malaria-exposed Ugandan children
Gonzalo R. Acevedo, Shahram Samiee, Mikias Ilala, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 2, pp. e1012943-e1012943
Open Access

Meeting report: Expert consultation on late arresting replication competent (LARC) malaria sporozoite vaccine research & development
Annie X. Mo, Glen C. McGugan, John Pesce
Vaccine (2025) Vol. 54, pp. 127009-127009
Closed Access

Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond
E. Adrianne Hammershaimb, Andrea A. Berry
Expert Review of Vaccines (2023) Vol. 23, Iss. 1, pp. 49-52
Open Access | Times Cited: 10

Hepatocytes and the art of killing Plasmodium softly
Camila Marques-da-Silva, Clyde Schmidt-Silva, Samarchith P. Kurup
Trends in Parasitology (2024) Vol. 40, Iss. 6, pp. 466-476
Closed Access | Times Cited: 3

A new landscape for malaria vaccine development
Alexander J Laurenson, Matthew B. Laurens
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012309-e1012309
Open Access | Times Cited: 3

Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate
Richard Thomson-Luque, Thomas C. Stabler, Kristin Fürle, et al.
Expert Review of Vaccines (2023) Vol. 23, Iss. 1, pp. 160-173
Open Access | Times Cited: 5

Determine the enzymatic kinetic characteristics of CYP3A4 variants utilizing artemether-lumefantrine
Xiaodan Zhang, Qingqing Li, Quan Zhou, et al.
Food and Chemical Toxicology (2023) Vol. 181, pp. 114065-114065
Closed Access | Times Cited: 2

Models of Protective Immunity against Schistosomes: Implications for Vaccine Development
R. Alan Wilson
Pathogens (2023) Vol. 12, Iss. 10, pp. 1215-1215
Open Access | Times Cited: 2

Implementation of a Randomized, Placebo-Controlled Trial of Live Attenuated Malaria Sporozoite Vaccines in an Indonesian Military Study Population
Khoriah Indrihutami, Krisin Chand, Rizka Fahmia, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 110, Iss. 5, pp. 892-901
Open Access

A paradigm for Africa-centric vaccine development in Equatorial Guinea
Peter F. Billingsley, Thomas L. Richie, Salim Abdulla, et al.
Trends in Parasitology (2024) Vol. 40, Iss. 5, pp. 362-366
Closed Access

20 years of BioMalPar: Building a collaborative malaria research network
Friedrich Frischknecht, Julian C. Rayner, Andrew P. Waters
Trends in Parasitology (2024) Vol. 40, Iss. 8, pp. 657-659
Open Access

Whole-sporozoite malaria vaccines: where we are, where we are going
Diana Moita, Miguel Prudêncio
EMBO Molecular Medicine (2024) Vol. 16, Iss. 10, pp. 2279-2289
Open Access

Identifying Plasmodium P36 and P52 antigens for co-administration with circumsporozoite protein to enhance vaccine efficacy
Sean C. Murphy, Naveen Yadav, Anya C. Kalata, et al.
Research Square (Research Square) (2024)
Closed Access

PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults
Anneth Tumbo, Freia-Raphaella Lorenz, Annie Yang, et al.
EBioMedicine (2024) Vol. 108, pp. 105364-105364
Open Access

Correlative humoral and cellular immunity to genetically attenuated malaria parasites in humans
Emil Colstrup, Rie Nakajima, Jelte M. M. Krol, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1 - Next Page

Scroll to top